News Conference News TCT 2024 TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS Todd Neale October 28, 2024
News Conference News ESC 2024 NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD Michael O'Riordan September 01, 2024
News Daily News Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years Yael L. Maxwell July 22, 2024
News Daily News Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years Yael L. Maxwell June 26, 2024
News Conference News NY Valves 2024 Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli Michael O'Riordan June 05, 2024
News Conference News EuroPCR 2024 Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY Michael O'Riordan May 17, 2024
News Conference News EuroPCR 2024 ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI Shelley Wood May 16, 2024
News Conference News EuroPCR 2024 Debate Continues on TAVI Choice for Women With Small Annuli Yael L. Maxwell May 14, 2024
News Conference News EuroPCR 2024 NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD Michael O'Riordan May 14, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
News Daily News DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants Shelley Wood January 17, 2024
News Daily News Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden Caitlin E. Cox December 12, 2023
News Conference News EACTS 2023 Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry Michael O'Riordan October 11, 2023
News Daily News Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted? Michael O'Riordan September 21, 2023